Why rare cancers deserve a greater focus and a more targeted approach 28 Feb 2018 The theme of Rare Disease Day 2018 is research. We asked Professor Winette van der Graaf, Professor of Personalised Oncology at The Institute of Cancer Research, London, to share her experiences of research into rare cancers and how this can improve outcomes for patients. Find out more Show/Hide
Evidence vs access – addressing the balance in assessing new cancer drugs 11 Oct 2017 A study in the BMJ last week has opened up a debate over the level of evidence needed before a drug is made available to patients. Here, our Science Information and Policy Officer, Dr Sam Dick, takes a look at the study in more detail. Find out more Show/Hide